Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies - Clinical Lung Cancer
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave - ScienceDirect
Prevalence of clinical lung diseases by smoking status and pack-years... | Download Scientific Diagram
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
![Corrigendum to “Docetaxel downregulates PD-1 expression via STAT3 in Tlymphocytes” [Clinical Lung Cancer 19 (2018) e675-e683] - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/48d0c5d4-f0e6-4447-8121-4b7ccb5b8e39/gr1.jpg "Corrigendum to “Docetaxel downregulates PD-1 expression via STAT3 in Tlymphocytes” [Clinical Lung Cancer 19 (2018) e675-e683] - Clinical Lung Cancer")
Corrigendum to “Docetaxel downregulates PD-1 expression via STAT3 in Tlymphocytes” [Clinical Lung Cancer 19 (2018) e675-e683] - Clinical Lung Cancer
PDF) ROS1-rearranged NSCLC With Secondary Resistance Mutation: Case Report and Current Perspectives
Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation - Clinical Lung Cancer
Home Page: Clinical Lung Cancer
HMGB1 is upregulated in clinical lung cancer tissues, and it is... | Download Scientific Diagram
PLOS ONE: Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens
Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients - Lung Cancer
PDF) Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small Cell Lung Cancer Patients Treated in the Community Practice Setting
The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020 - The Lancet Regional Health – Western Pacific
PDF) BRCA1: A new genomic marker for non-small-cell lung cancer
Clinical Characteristics and Prognosis of Patients With Advanced Non–Small‐cell Lung Cancer Who Are Ineligible for Clinical Trials | Semantic Scholar
Clinical Lung Cancer | Elsevier Pharma Solutions
PDF) The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors
publications | Catherinn
MAGE-A3 expression in A549 cells, subcutaneous tumors, and clinical... | Download Scientific Diagram
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non–Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations - Clinical Lung Cancer
Clinical Activity of Afatinib in Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study - Clinical Lung Cancer
CHCWM clinical trial published in esteemed lung cancer journal - CHCWM - Cancer & Hematology Centers of West Michigan
Clinical Lung Cancer (@ClinicalLung) / Twitter
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy - ScienceDirect
